In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 23rd, 2010 | 32 | Yes |
Popular Name: 1-[4-[1-ethyl-4-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrazol-3-yl]phenyl]-3-phenyl-urea 1-[4-[1-ethyl-4-(1H-pyrrolo[2,3-…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.62 | 10.83 | -19.04 | 3 | 7 | 0 | 88 | 422.492 | 5 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AURKA-2-E | Serine/threonine-protein Kinase Aurora-A (cluster #2 Of 3), Eukaryotic | Eukaryotes | 631 | 0.27 | Binding ≤ 10μM |
AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2 | 0.38 | Binding ≤ 10μM |
IGF1R-1-E | Insulin-like Growth Factor 1 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 158 | 0.30 | Binding ≤ 10μM |
INCE-1-E | Inner Centromere Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.38 | Binding ≤ 10μM |
LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 398 | 0.28 | Binding ≤ 10μM |
MET-1-E | Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 316 | 0.28 | Binding ≤ 10μM |
ROCK1-1-E | Rho-associated Protein Kinase 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 398 | 0.28 | Binding ≤ 10μM |
CP2C9-1-E | Cytochrome P450 2C9 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 100 | 0.31 | ADME/T ≤ 10μM |
CP2D6-1-E | Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 100 | 0.31 | ADME/T ≤ 10μM |
Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 79 | 0.31 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 316 | 0.28 | Binding ≤ 1μM |
INCE_HUMAN | Q9NQS7 | Inner Centromere Protein, Human | 1.99526231 | 0.38 | Binding ≤ 1μM |
IGF1R_HUMAN | P08069 | Insulin-like Growth Factor I Receptor, Human | 158 | 0.30 | Binding ≤ 1μM |
ROCK1_HUMAN | Q13464 | Rho-associated Protein Kinase 1, Human | 398 | 0.28 | Binding ≤ 1μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 631 | 0.27 | Binding ≤ 1μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 1.99526231 | 0.38 | Binding ≤ 1μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 398 | 0.28 | Binding ≤ 1μM |
MET_HUMAN | P08581 | Hepatocyte Growth Factor Receptor, Human | 316 | 0.28 | Binding ≤ 10μM |
INCE_HUMAN | Q9NQS7 | Inner Centromere Protein, Human | 1.99526231 | 0.38 | Binding ≤ 10μM |
IGF1R_HUMAN | P08069 | Insulin-like Growth Factor I Receptor, Human | 158 | 0.30 | Binding ≤ 10μM |
ROCK1_HUMAN | Q13464 | Rho-associated Protein Kinase 1, Human | 398 | 0.28 | Binding ≤ 10μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 631 | 0.27 | Binding ≤ 10μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 1.99526231 | 0.38 | Binding ≤ 10μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 398 | 0.28 | Binding ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 79 | 0.31 | Functional ≤ 10μM |
CP2C9_HUMAN | P11712 | Cytochrome P450 2C9, Human | 100 | 0.31 | ADME/T ≤ 10μM |
CP2D6_HUMAN | P10635 | Cytochrome P450 2D6, Human | 100 | 0.31 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
Apoptotic cleavage of cellular proteins | |
CD28 co-stimulation | |
Cell surface interactions at the vascular wall | |
CTLA4 inhibitory signaling | |
CYP2E1 reactions | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Fatty acids | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
G alpha (12/13) signalling events | |
GPVI-mediated activation cascade | |
Growth hormone receptor signaling | |
IRS-related events triggered by IGF1R | |
Miscellaneous substrates | |
Mitotic Prometaphase | |
PECAM1 interactions | |
Platelet Adhesion to exposed collagen | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Resolution of Sister Chromatid Cohesion | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Sema4D induced cell migration and growth-cone collapse | |
Sema4D mediated inhibition of cell attachment and migration | |
Separation of Sister Chromatids | |
SHC-related events triggered by IGF1R | |
Signaling by SCF-KIT | |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | |
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | |
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | |
VEGFA-VEGFR2 Pathway | |
Xenobiotics |
No pre-computed analogs available. Try a structural similarity search.